Next, to evaluate whether IL-6 KO mice develop lasting immunologic memory after doxorubicin treatment, we re-transplanted leukemia cells into previously cured IL-6 KO mice or naive controls (Fig. 4c) and monitored leukemia progression. Here, IL6 is linked to leukemia.